Innovative technology, MonaLisa Touch, enhances intimacyLas Vegas Minimally Invasive Surgery and Women’s Pelvic Health Center, a part of WellHealth Medical Group, is now offering the MonaLisa Touch laser technology. This new technology has been shown to reverse the deterioration of the vaginal walls associated with a loss of estrogen.
Estrogen loss can be due to aging, hormonal treatments for breast cancer and other conditions. Millions of women suffer silently with symptoms such as vaginal dryness, increased vaginal pH levels, itching, irritation and even pain during intercourse. With treatment from the MonaLisa Touch method, women can regain their quality of life and sexuality. The treatment method is one of the most advanced techniques currently available for vaginal photorejuventation. The laser technology, developed in Italy, delivers short CO2 ablative laser pulses to the vaginal wall, decreasing the symptoms seen with vaginal atrophy.
Several patients at the Las Vegas Minimally Invasive Surgery-Women’s Pelvic Health Center have started the MonaLisa Touch treatment and are already reporting relief from their symptoms. Dr. K. Warren Volker, the lead doctor performing this newest treatment option, explained, “The revolutionary treatment presents a new path for women who are experiencing vaginal atrophy. Mother Nature hasn’t gotten the memo that women are living longer lives and aren’t ready to give up on their sexuality. MonaLisa Touch gives women a choice they’ve never had before.” After the recommended full cycle of three outpatient treatments over 45 to 60 days, patients receiving the treatment will notice the cessation of their symptoms and a noticeable improvement in their day-to-day life.
Dr. Melissa Gutierrez is the assistant medical director of Las Vegas Minimally Invasive Surgery-Women’s Pelvic Health Center as well as its fellowship program. “I believe we became the third place in the United States offering this technology. It is really exciting to be a part of this innovation. We get to teach this technique to our fellowship doctors, and it is a very unique program.”
Las Vegas Minimally Invasive Surgery and Women’s Pelvic Health Center will be one of only four training facilities in the United States to teach physicians how to use the laser technology.
According to medical research, as many as 50 percent of postmenopausal women in the United States suffer from vaginal atrophy; an estimated 16 million women are affected. This percentage can be even higher in specific subcategories of women, such as those who have a history of breast cancer. In one study of breast cancer survivors, vaginal dryness was a symptom in 23.4 percent of the premenopausal patients. That number skyrockets to 61.5 percent in postmenopausal patients.
The treatment has also provided a new option for breast cancer survivors suffering from vaginal atrophy and low estrogen levels. Because MonaLisa Touch is a non-hormonal option, cancer survivors will not develop cancerous cells. The treatment supplies a solution to messy, expensive creams and, in some cases, hormone replacement therapy.
“Unfortunately, estrogen replacement therapy is expensive, and even though health insurance may cover a little of the cost, it can still cost hundreds of dollars a month,” Dr. Gutierrez said. “With this technology, once it is performed, there is no longer the cost of estrogen replacement for years.” Another benefit is that there are not the side effects and risks associated with replacement therapy.
“I want to assure anyone considering this procedure that it is so quick, easy and pain-free. It takes about five minutes. I have never had a patient complain of pain,” Dr. Gutierrez stated.
WellHealth Medical Group offers patients an integrated network of doctors, nurses and medical specialists. For more information, visit wellhealthqc.com.